DR April C Watt
Research Fellow
The Sir Peter MacCallum Department of Oncology
11 Scholarly works
0 Projects
HIGHLIGHTS
2026
Conference Proceedings
Abstract GS3-06: Rb Functions as a Transcriptional Activator of ER Targets Following CDK4/6 Inhibition in Luminal Breast Cancer
DOI: 10.1158/1557-3265.sabcs25-gs3-062026
Journal article
Rb-driven transcription limits its tumour-suppressive effects in breast cancer
DOI: 10.1038/s41586-026-10886-w2024
Thesis / Dissertation
Epigenetic Consequences of CDK4/6 Inhibition in Breast Cancer
2024
Journal article
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
DOI: 10.1158/2159-8290.CD-23-09542022
Journal article
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer
DOI: 10.1186/s13058-022-01510-62022
Journal article
Analysis of functional surfaces on the actin nucleation promoting factor Dip1 required for Arp2/3 complex activation and endocytic actin network assembly
DOI: 10.1016/j.jbc.2022.1020192021
Journal article
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
DOI: 10.1038/s43018-020-00135-y
RECENT SCHOLARLY WORKS
2018
Conference Proceedings
CDK4/6 inhibition triggers an antitumor immune response
DOI: 10.1158/2326-6074.TUMIMM17-B042017
Journal article
CDK4/6 inhibition triggers anti-tumour immunity
DOI: 10.1038/nature234652017
Conference Proceedings
CDK4/6 inhibition directly enhances an anti-tumor immune response in breast cancer
DOI: 10.1158/1538-7445.AM2017-1634